79 related articles for article (PubMed ID: 2090223)
21. Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.
Laguna F; Videla S; Jiménez-Mejías ME; Sirera G; Torre-Cisneros J; Ribera E; Prados D; Clotet B; Sust M; López-Vélez R; Alvar J;
J Antimicrob Chemother; 2003 Sep; 52(3):464-8. PubMed ID: 12888588
[TBL] [Abstract][Full Text] [Related]
22. Post-kala-azar dermal Leishmaniasis and uveitis in an HIV-positive patient.
Ramos A; Cruz I; Muñez E; Salas C; Fernández A; Alvarez-Espejo T
Infection; 2008 Mar; 36(2):184-6. PubMed ID: 18327683
[No Abstract] [Full Text] [Related]
23. [Visceral leishmaniasis and HIV infection].
Pieltain Alvarez-Arenas R; Audibert Mena L; Pérez Mochales J; Tewfick M; Ortiz Alonso FJ; de Miguel Novoa MP
Rev Clin Esp; 1991 Jul; 189(3):150. PubMed ID: 1947391
[No Abstract] [Full Text] [Related]
24. [Visceral leishmaniasis and HIV infection: the diagnostic and therapeutic problems].
Rocha PS; Rebocho L; Alvoeiro L; Lourenço G; Branco R; Victorino RM; de Moura MC
Acta Med Port; 1993 Nov; 6(11):543-6. PubMed ID: 8140923
[TBL] [Abstract][Full Text] [Related]
25. [Pancreatic toxicity of antimonials in patients with infections].
Sánchez LA; Ferrero OL; Zubero Z; Teira R; Muñoz J; Baraia-Etxaburu J; Santamaría JM
Rev Esp Enferm Dig; 2000 Nov; 92(11):765-6. PubMed ID: 11468860
[No Abstract] [Full Text] [Related]
26. AA-amyloidosis caused by visceral leishmaniasis in a human immunodeficiency virus-infected patient.
de Vallière S; Mary C; Joneberg JE; Rotman S; Bullani R; Greub G; Gillmore JD; Buffet PA; Tarr PE
Am J Trop Med Hyg; 2009 Aug; 81(2):209-12. PubMed ID: 19635871
[TBL] [Abstract][Full Text] [Related]
27. Multiple relapses of visceral leishmaniasis in an adolescent with idiopathic CD4+ lymphocytopenia associated with novel immunophenotypic and molecular features.
Prigione I; Castagnola E; Imberti L; Gambini C; Gradoni L; Dianzani U; Ramenghi U; Giacopelli F; Moretta A; Moretta L; Plebani A; Fischer A; Pistoia V
Pediatr Infect Dis J; 2009 Feb; 28(2):161-3. PubMed ID: 19106781
[TBL] [Abstract][Full Text] [Related]
28. Treatment of visceral leishmaniasis.
Wali JP; Sharma SK; Guleria JS
J Assoc Physicians India; 1984 Sep; 32(9):813-4. PubMed ID: 6096351
[No Abstract] [Full Text] [Related]
29. [First case in Russia of coinfection of visceral leishmaniasis and HIV-infection].
Konstantinova TN; Lysenko AIa; Lavdovskaia MV; Imamkuliev KD; Sel'kova EP; Anchukova EL; Ageenko TA
Ter Arkh; 1998; 70(11):31-3. PubMed ID: 9949454
[No Abstract] [Full Text] [Related]
30. Treatment of visceral leishmaniasis.
Ozsoylu S
Pediatr Hematol Oncol; 2006; 23(5):449-51; author reply 455-7. PubMed ID: 16728366
[No Abstract] [Full Text] [Related]
31. Take HAART.
Keenihan SH
Trends Parasitol; 2002 Jun; 18(6):244-5. PubMed ID: 12036733
[No Abstract] [Full Text] [Related]
32. Diffuse nodular regenerative hyperplasia of the liver associated with human immunodeficiency virus and visceral leishmaniasis.
Fernandez-Miranda C; Colina F; Delgado JM; Lopez-Carreira M
Am J Gastroenterol; 1993 Mar; 88(3):433-5. PubMed ID: 8438854
[TBL] [Abstract][Full Text] [Related]
33. [Visceral leishmaniasis with small intestine and colon involvement in a patient with HIV infection].
Diego Mediavilla J; Omar M; Jiménez-Alonso J; Miranda C; Aliaga L
Enferm Infecc Microbiol Clin; 1995; 13(6):377-8. PubMed ID: 7654839
[No Abstract] [Full Text] [Related]
34. Fluconazole plus allopurinol in treatment of visceral leishmaniasis.
Torrús D; Boix V; Massa B; Portilla J; Pérez-Mateo M
J Antimicrob Chemother; 1996 May; 37(5):1042-3. PubMed ID: 8737162
[No Abstract] [Full Text] [Related]
35. [The clinical and evolutional characteristics of visceral leishmaniasis in patients with HIV infection].
Delgado Fernández M; García Ordoñez MA; Martos Pérez F; Reguera Iglesias JM; Jiménez Oñate F; Colmenero Castillo JD
An Med Interna; 1997 Oct; 14(10):506-10. PubMed ID: 9424140
[TBL] [Abstract][Full Text] [Related]
36. Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS.
Calza L; D'Antuono A; Marinacci G; Manfredi R; Colangeli V; Passarini B; Orioli R; Varoli O; Chiodo F
J Am Acad Dermatol; 2004 Mar; 50(3):461-5. PubMed ID: 14988693
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS).
Pourahmad M; Hooshmand F; Rahiminejad M
Int J Dermatol; 2009 Jan; 48(1):59-61. PubMed ID: 19126052
[TBL] [Abstract][Full Text] [Related]
38. [Leishmaniasis in a patient with HIV infection and pulmonary tuberculosis. Is it more than a casual association?].
Roig R; Salavert M; Navarro V; Nieto A; Millán F; Grau M
Enferm Infecc Microbiol Clin; 1989; 7(6):338-9. PubMed ID: 2490455
[No Abstract] [Full Text] [Related]
39. A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection.
Ritmeijer K; Dejenie A; Assefa Y; Hundie TB; Mesure J; Boots G; den Boer M; Davidson RN
Clin Infect Dis; 2006 Aug; 43(3):357-64. PubMed ID: 16804852
[TBL] [Abstract][Full Text] [Related]
40. Evaluating treatment for visceral leishmaniosis.
Vercammen F
J Am Vet Med Assoc; 1996 Oct; 209(8):1379. PubMed ID: 8870724
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
